Opendata, web and dolomites

EVA

EVA - patient ventilation beyond limits

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 EVA project word cloud

Explore the words cloud of the EVA project. It provides you a very rough idea of what is the project "EVA" about.

circulation    penetration    organizing    entered    executed    conservative    assistance    workshops    leaders    standard    blood    reducing    marketing    thin    sheer    prevent    emergency    patient    meeting    markets    distributors    400    suction    elective    lungs    care    trials    q3    sessions    demonstration    thick    eva    full    catheter    trl6    sold    ventilate    russia    careful    usa    outcome    expiratory    pressures    500    2011    protected    stress    invasive    ventrain    injury    negative    countries    basic    ventilator    registrations    16    tube    lung    patients    patent    billion    ensured    generation    expiration    academic    globally    centers    manufactured    designed    innovative    ventilation    clinical    close    opinion    ireland    automated    market    marking    disposable    ce    reg    world    medical    china    flagship    training    mechanically    device    families    first    icu    netherlands    instead    manual    ventinova    2nd    form    brand    surgical    2016    launch   

Project "EVA" data sheet

The following table provides information about the project.

Coordinator
VENTINOVA MEDICAL BV 

Organization address
address: MEERENAKKERPLEIN 7
city: EINDHOVEN
postcode: 5652 BJ
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Project website https://www.ventinovamedical.com/successes-innovation-project-2/
 Total cost 2˙397˙540 €
 EC max contribution 1˙890˙000 € (79%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2. (PRIORITY 'Industrial leadership')
 Code Call H2020-FTIPilot-2015-1
 Funding Scheme IA
 Starting year 2015
 Duration (year-month-day) from 2015-11-01   to  2018-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VENTINOVA MEDICAL BV NL (EINDHOVEN) coordinator 793˙261.00
2    UNIVERSITAETSKLINIKUM FREIBURG DE (FREIBURG) participant 621˙250.00
3    UNITRON INNOTECH BV NL (HENGELO) participant 390˙999.00
4    REGION HOVEDSTADEN DK (HILLEROD) participant 63˙000.00
5    ASSISTANCE PUBLIQUE HOPITAUX DE PARIS FR (PARIS) participant 21˙487.00

Map

 Project objective

EVA - Expiratory Ventilation Assistance – , or expiration by suction, is an innovative method to mechanically ventilate patients and is a key step in ventilation towards less-invasive, tailored and improved patient care as it enables: 1. full ventilation through a thin catheter instead of a thick tube 2. low and – if needed – negative pressures in the lungs promoting blood circulation 3. controlling the expiration, reducing sheer stress, which may prevent lung injury and improve patient outcome.

The EVA technology has already been on the market for some years in its most basic form: the manual, disposable emergency ventilator Ventrain®. Since market launch in 2011, Ventrain® is now being sold by 16 distributors in over 20 countries. Ventinova’s flagship is the “EVA device”: a fully automated ventilator based on EVA technology meeting the emerging needs of less invasive, tailored and improved patient care. First is focused on the large markets of elective surgical procedures and emergency care (€ 400 M, globally) and in 2nd generation on ICU-ventilation (€ 500 M, globally), before becoming ‘standard care’ (€ 4.6 billion, globally). The device, currently at TRL6, is still in development and CE marking is expected in Q3 2016. Next to marketing activities, such as organizing workshops and training sessions, and careful selection and support of distributors, penetration of the conservative medical market should be ensured by demonstration of better and tailored patient care using EVA ventilation in pre-clinical studies and controlled clinical trials. These are to be designed and executed in close collaboration with Key Opinion Leaders of established and world leading academic medical centers.

The described technology and products are protected by 5 patent families and design and brand registrations. The products are manufactured in The Netherlands and a dedicated catheter in Ireland. After CE marking, large non-EU markets are to be entered (e.g. USA, China, Russia).

 Deliverables

List of deliverables.
Reports of communication activities Documents, reports 2019-09-06 09:01:40
Evaluation of benefit personalised care Documents, reports 2019-09-06 09:01:40
Obtained FDA approval Websites, patent fillings, videos etc. 2019-09-06 09:01:40
Submission for publication Documents, reports 2019-09-06 09:01:40
Workshop organisation Websites, patent fillings, videos etc. 2019-09-06 09:01:40
Annual showcasing Websites, patent fillings, videos etc. 2019-09-06 09:01:40
Obtained CE marking Websites, patent fillings, videos etc. 2019-09-06 09:01:40
Evaluation of lung protective effects Documents, reports 2019-09-06 09:01:40
Evaluation of safe use in Pigs Documents, reports 2019-09-06 09:01:40

Take a look to the deliverables list in detail:  detailed list of EVA deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EVA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EVA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.)

Innovation Principle (2019)

Developing an Innovation-Friendly Legislative Culture – the Innovation Principle at Work

Read More  

PULSe (2017)

Pervasive Ubiquitous Lightwave SEnsor

Read More  

MedEye (2017)

Accelerated market launch of MedEye, a plug-and-play medication safety solution

Read More